The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: PACLITAXEL.     Injury: Malignant neoplasm progression     Quarter: 2016Q3

Total Records: 12     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
121422262 PACLITAXEL. Malignant neoplasm progression MYLAN 0.00 0 20160720 IT
125420391 PACLITAXEL. Malignant neoplasm progression ASTRAZENECA 69.00 YR F 0 20160708 GR
125474341 PACLITAXEL. Malignant neoplasm progression ASTRAZENECA 54.00 YR F 0 20160711 GR
125837661 PACLITAXEL. Malignant neoplasm progression ELI LILLY AND CO 50.00 YR M 0 20160722 ES
125931321 PACLITAXEL. Malignant neoplasm progression MYLAN 0.00 0 20160726 IT
125976661 PACLITAXEL. Malignant neoplasm progression TEVA 0.00 M 0 20160727 IT
126341832 PACLITAXEL. Malignant neoplasm progression ELI LILLY AND CO 62.00 YR M 0 20160829 JP
126624561 PACLITAXEL. Malignant neoplasm progression BRISTOL MYERS SQUIBB 68.00 YR M 0 20160817 US
126950724 PACLITAXEL. Malignant neoplasm progression ELI LILLY AND CO 80.78 YR M 0 20160923 JP
127140052 PACLITAXEL. Malignant neoplasm progression BAUSCH AND LOMB 39.00 YR M 0 20160916 JP
127253421 PACLITAXEL. Malignant neoplasm progression ELI LILLY AND CO 65.00 YR M 0 20160908 JP
127393121 PACLITAXEL. Malignant neoplasm progression AVENTIS 39.00 YR M 0 20160913 JP

Total Records: 12     Number of Pages: 1